1Arakawa S, Yasuda M, Nagata M, et al. Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese popula- tion: the Hisayama Study. Invest Ophthalmol Vis Sci, 2011, 52: 5905-5909.
2Rogers S, Mclntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the Unit- ed States, Europe, Asia, and Australia. Ophthalmology, 2010, 117: 313-319.
3Ip MS, Scott IU, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with maeular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5. Arch Ophthalmol, 2009,127:1101-1114.
4Jain N, Stinnett SS, Jaffe GJ. Prospective study of a fluoeinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results. Ophthalmology, 2012, 119: 132-137.
5Yeh WS, Hailer JA, Lanzetta P, et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology, 2012. [Epub ahead of print].
6Hailer JA, Bandello F, Belfort R, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology, 2011,118: 2453-2460.
7Hailer JA, Bandello F, Belfort R, et ol. Randomized, sham-controlled trial of dexamethasone intravitre01 implant in patients with macular edema due to retinal vein occlusion. Ophthalmology, 2010, 117: 1134-1146.
8Lin JM, Chiu YT, Hung PT, et al. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide. Retina, 2007, 27: 180-189.
9Kinge B, Stordahl PB, Forsaa V, et al. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study. Am J Ophthalmol, 2010, 150: 310-314.
10Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point n,suits of a phase Ⅲ study. Ophthahnology, 2010, 117: 1124-1133.
